Phase 3 Iron-deficiency Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Iron-Deficiency Anemia
AMAG Pharmaceuticals, Inc.75 enrolled15 locationsNCT03893045
Recruiting
Phase 2Phase 3
IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study
Surgery--ComplicationsIron-deficiencySpinal Fusion+4 more
Columbia University120 enrolled1 locationNCT07217873
Recruiting
Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
Iron-Deficiency Anemia
Auerbach Hematology Oncology Associates P C104 enrolled1 locationNCT04268849
Recruiting
Phase 3
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
PregnancyIron-Deficiency Anemia
Women and Infants Hospital of Rhode Island300 enrolled8 locationsNCT05462704
Recruiting
Phase 3
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
Gynecologic CancerAnemiaIron-deficiency
AHS Cancer Control Alberta82 enrolled1 locationNCT05407987
Completed
Phase 3
Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women in their third trimester: REVAMP-TT
HypophosphataemiaFoetal anaemiaInfection+2 more
Training and Research Unit of Excellence (TRUE), Malawi590 enrolled1 locationACTRN12621001239853